Accueil Répertoire des industries listées

Répertoire des industries listées

CompanySite webIntérêtsIntérêt pour l'ARNLocationContact EmailNotes
Agilenthttps://www.agilent.com/RNA reagents, nucleic acid synthesis, apparatusdiscovery/development, consultingCanadapearl.lee@agilent.com
Cell Signalinghttps://www.cellsignal.com/assays and experiment productsmaterials distributorCanadacabrown@cellsignal.com, ryan.tay@cellsignal.com
Helmholtz Institute for RNA-based Infection Research (HIRI)https://www.helmholtz-hiri.de/en/RNA diagnostics, drug and therapeutic development for infectious diseasesdiscovery/developmentGermanysylke.kieliba@helmholtz-hiri.de
https://www.lexogen.com/https://www.lexogen.com/RNA sequencingdiscovery/developmentAustriaLukas Paul (lukas.paul@lexogen.com) info@lexogen.com , amra.dedic@lexogen.comFrom website: +43 (0) 1 345 1212
NeoVentures Biotechnology Inchttps://neoaptamers.com/aptamers for diagnostics, food, etc, custom aptamer system production; https://neoaptamers.com/; Canada (and more)discovery/developmentCanadaGregory Penner gpenner@neoventures.ca (CEO); e.rodrigues@neoventures.ca (liaison)
NeuroSense Therapeuticshttps://www.neurosense-tx.com/ALS drug developmentdiscovery/development, end-userIsrael / USA
AbCellerahttps://abcellera.com/antibody immunotherapiesdiscovery/developmentCanadaRaffi Tonikian (raffi.tonikian@abcellera.com)From website: https://abcellera.com/contact/ , 604.559.9005
Abogenhttps://www.abogenbio.com/mRNA delivery technologydiscovery/developmentChinasponsors from European RNA meeting. https://www.abogenbio.com/contact/
Accent Therapeuticshttps://accenttx.com/small molecule therapeutics for different cancersdiscovery/developmentUSAsponsors from European RNA meeting. For general inquiries: contactus@accenttx.com, For partnership opportunities: collaborations@accenttx.com (339) 970-7400
Acuitas Therapeuticshttps://acuitastx.com/mRNA LNP formulationsdiscovery/development, end-userCanadaYing Tam (ytam@acuitastx.com)
AdMare Bioinnovationshttps://www.admarebio.com/en/company building, networking, financing; https://www.admarebio.com/;consultingCanadaDr. Mounia Azzi (mazzi@admarebio.com), achaubey@admarebio.com - Senior Associate and Partnership Managerhttps://www.admarebio.com/en/contact-us
Ajinomoto BioPharma Servicehttps://ajibio-pharma.ajinomoto.com/platform for RNA technologiesdiscovery/development, materials distributorJapan and globalaji-bio-pharma@asv.ajinomoto.com
Alnylam Parmaceuticalshttps://www.alnylam.com/siRNA therapiesdiscovery/developmentUSAMuthiah (Mano) Manoharan (mmanoharan@alnylam.com)
Altascienceshttps://www.altasciences.com/CRO; cité de la Biotech (Laval)discovery/developmentCanada and globalDanielle Salha (mdsalha@altasciences.com),contact@altasciences.com 450 973-6077
Amgenhttps://www.amgen.ca/large pharmaceutical companydiscovery/developmentGlobal1 (800) 665-4273 (Canada Only), Media contact: natasha.bond@amgen.com
Amino Labshttps://amino.bio/biotechnology, educationdiscovery/developmentCanada/USAJulie Legault (julie@amino.bio)
Amira Medical Technologiesmedical, diagnostic toolsCanadaGeorge Templeton (george@amiramedical.com)
Applied Biological Materialshttps://www.abmgood.com/RNA research toolsmaterials distributorCanadaAngela Trinh (https://www.linkedin.com/in/angela-trinh-3031a9128/)
Arbutus Biopharmahttps://www.arbutusbio.com/drug development, HBV treatmentdiscovery/development, end-userCanada/USABusiness Development: bd@arbutusbio.com , Human Resources: hr@arbutusbio.com, Investors: ir@arbutusbio.com
ARNA Therapeuticshttps://amorchem.com/portfolio/srsf3/antisense to regulate SMAdiscovery/developmentCanadaJean-Pierre Julien (jean-pierre.julien@fmed.ulaval.ca)
Arrakis Therapeuticshttps://arrakistx.com/RNA targeted small molecule medicinesdiscovery/developmentUSAFrom website: info@arrakistx.com
Arraystarinfo@arraystar.com
Ascidian Therapeuticshttps://ascidian-tx.com/RNA editing and replacing human exonsdiscovery/developmentUSAoutreach@ascidian-tx.com, advocacy@ascidian-tx.com
AstraZenecalarge pharmaceutical companydiscovery/developmentUSA and global
Asuragenhttps://asuragen.com/molecular diagnostic technology and materialsdiscovery/development, materials distributorUSAhttps://asuragen.com/contact/
Atlanta Therapeuticshttps://www.atalantatx.com/silencing RNAs for neurodegenerative diseasediscovery/development, end-userUSALisa Raffensperger (lisa@tenbridgecommunications.com) 617-903-8783sponsors from European RNA meeting. Other email: info@atalantatx.com
Atomic AI
Australia PhD Network
Avantor (VWR)https://www.vwr.com/provide services and technology to support manufacturing of therapeuticsmaterials distributorCanada and globalFrom website: services@avantorsciences.com
Axelys
Azentahttps://www.azenta.com/general lab products & services (including RNA seq and bioinfo, biobanking and all sorts of consumables and instruments); https://www.azenta.com/; cité Biotech, Laval and global locationsdiscovery/developmentCanadahttps://www.azenta.com/contact-us
Beam Me Up (BMU) Augmented Intelligencehttps://bmu.co/AI, VR - genomic applications, neurobiometrics toolsCanadaYan Cyrhttps://bmu.co/contact/
Beckman Coulterhttps://www.beckmancoulter.com/large materials distributormaterials distributorglobalSiu, Raymond (RSIU@beckman.com), Patel, Trushar (trushar.patel@uleth.ca)
Bio-Rad2012
BioArohttps://bioaro.com/genetic and microbiome testingend-userCanadasupport@bioaro.com, 403-250-2221
Bioasis TechnologiesVancouverBritish Columbiawww.bioasis.us
Bioecholuma.mohammad@bioecho.de
Biomerieux
Bioquebec
Biosplicehttps://www.biosplice.com/default.aspxAlternative splicing in diseasediscovery/development, end-userUSAhttps://www.biosplice.com/contact-us/default.aspx , +1 858 926 2900
BioTeCanadahttps://www.biotech.ca/support commercial development of biotech in Canada (business development/networking, advocacy, industry/public awareness)consultingCanadaMr. Andrew Casey, President (613-230-5585)
Biotechandreas.kuhn@biontech.dePlatinum (21-12-2022)priority
Biotech
Biovectrahttps://www.biovectra.com/Pharmaceutical, biomanufacturing, mRNAdiscovery/developmentCanadaAndrew Mitchell (agmitchell@biovectra.com)
BioVectra Incmsauer@biovectra.com>
BlackTraceanne.mccloskey@blacktrace.com
BMK Gene
Boehringer Ingelheim
BoiVectra Inchttps://www.biovectra.com/manufacturing synthetic and fermented small moleculesdiscovery/developmentCanadaMarc Sauer (msauer@biovectra.com)"clinical to commercial scale production"
BrainDTechhttps://www.braindtech.com/miRNA biomarkers for neurodegenerative diseasediscovery/developmentItalysponsors from European RNA meeting. Contact for Italy site: info@braindtech.com P. IVA: 09593150965
BrandelSales@Brandel.com2014
Bristol Myers
BVF Partners L.P.
Cambridge Healthcare Research
Capstan Therapeutics
CapstanTx
Catenion
CederlaneAna.Pereira@cedarlanelabs.com / Ryan.Goyette@cedarlanelabs.com / marketing@cedarlane.ca2019
Celgene Corporation
Cell Cartawww.cellcarta.comdrug development, processing clinical samplesdiscovery/developmentCanada and globalinfo@cellcarta.com , +1 (514) 360-3600
Cellernahttps://www.cellerna.bio/RNA Productiondiscovery/developmentGermany
Charles RiverLavalQuebecCROwww.criver.comASO screening, in vivo toxicity
Charles Rivers Laboratorieshttps://www.criver.com/Preclinical and clinical laboratory, gene therapy and cell therapy servicesdiscovery/developmentglobalEdward Short (edward.short@crl.com)
Chinook Contract Researchhttps://ccr01.com/Livestock/ food animal production chain, antimicrobial and medical devicesconsulting, discovery/developmentCanada(403) 714-7922, https://ccr01.com/contact-us
Covant
CQDM
Critical Care DxLinkedIn: https://www.linkedin.com/in/critical-care-dx-ltd-company-414084197/overlay/contact-info/chip technology, biotechnology, extraction/purification, biomarkerend-userCanadaAmir Sanati-Nezhad (as.nezhad@criticaredx.com)
Critical Dxas.nezhad@criticaredx.com
CSL Vifor
CureVachttps://www.curevac.com/en/mRNA therapeutics for prophylactic treatmentdiscovery/developmentGermanysponsors from European RNA meeting. P +49 7071 9883 https://www.curevac.com/en/contact/
Cytivahttps://www.cytivalifesciences.com/en/caprovide services and technology to support manufacturing of therapeuticsmaterials distributorCanada and globalEric BrassardFrom website: ken.elder@cytiva.com
Cytophagehttps://cytophage.com/bacteriophages, biotechnology, agriculture, medicaldiscovery/developmentCanadaBradley Cookhttps://cytophage.com/contact-us/
Cytosurge
D-Mark Biosciencesrichard.mcelligott@d-markbio.com2019
D5PharmaTorontoOntariowww.d5pharma.com
Dalton Pharma ServicesTorontoOntariowww.dalton.com
Deep GenomicsTorontoOntarioComputational Designwww.deepgenomics.com
Defence therapeuticshttps://defencetherapeutics.com/enhanced delivery (protein, RNA or DNA); https://defencetherapeutics.com/; Cité Biotech, Lavaldiscovery/developmentCanadaDr. Simon Beaudoin (CTSO,info@defencetherapeutics.com)
Defense TherapeuticsLavalQuebecEnhanced delivery systems
Dicerna pharmaceuticals
Dicerna pharmaceuticals (acquired by Novo Nordisk)https://www.novonordisk-us.com/inhibitory RNA (RNAi) to treat diseasediscovery/developmentglobalsponsors from European RNA meeting. Acquired by Novo Nordisk in 2021. Media contacts: Mette Kruse Danielsen +45 3079 3883, mkd@novonordisk.com Michael Bachner (US) +1 609 664 7308, mzyb@novonordisk.com
Disc Medicine
DNA Powerhttps://www.dnapower.com/medical/genetic testingend-userCanadaLois Nahirneyhttps://www.dnapower.com/contact/
Do Bio
Dynamic Biosensorkatharina.rant@dynamic-biosensors.com5
Eclipseryan.odonnell@eclipsebio.com
ElarexBurlingtonOntarioDelivery - LNPwww.elarexinc.com
Element Bioscienceswww.elementbiosciences.comgenomics, interest in RNA Canada and RIboclub (www.elementbiosciences.com)discovery/developmentCanadian officeBen Li (Sales Executive – Canada, ben.li@elembio.com )
ElevateBio
Eleven Therapeuticshttps://eleventx.com/RNA therapeuticsdiscovery/developmentUnited Kingdom
Eli Lilly Canadahttps://www.lilly.com/en-CA/pharmaceutical research and manufacturingdiscovery/development, consultingCanada and globalJosee Lefebvre (lefebvre_josee@lilly.com)Scientific Partnering: https://www.lilly.com/partners/connect, https://www.lilly.com/en-CA/discovery/scientific-partnering
Ella Biotechhit-reply@linkedin.comnot deliverable
Elsevierr.conway@elsevier.com
EMD Millipore2011
enGenewww.engene.comDelivery - Chitosan for delivery of genetic medicinesdiscovery/developmentCanadaFrom website: partnerships@engene.com
Entos pharmahttps://www.entospharma.com/gene delivery (mRNA or DNA); https://www.entospharma.com/; Albertadiscovery/development, end-userCanada
Entos PharmaceuticalsEdmontonAlbertaDelivery - LNPwww.entospharma.com
Epitopeahttps://www.epitopea.com/Not an RNA company, but interested in mRNA vaccines, Cancer vaccine based on non-canonical ORF derived MHC peptides, computational identification algorithmdiscovery/developmentCanadaSteven Klein (Steven.Klein@Epitopea.com)
Evahcorphttps://www.evahcorp.ca/en/animal health; https://www.evahcorp.ca/; cité Biotech Laval (and more)discovery/developmentCanadaFrédéric Leduc (CSO)
Evonik Degussa CanadaMaitlandOntarioDelivery - LNPwww.corporate.evonik.com
Exonatehttps://www.exonate.com/Small molecules to regulate splicingdiscovery/development, end-userUnited KingdomDavid Bates (David.Bates@nottingham.ac.uk)
ExpertConnect
Eyam HealthSurreyBritish Columbiawww.eyamhealth.com
Feldan Therapeuticshttps://www.feldan.com/Medical,lungs and skin, pharmaceuticaldiscovery/development, end-userCanadaDavid Guayhttps://www.feldan.com/contact
First Manhattan Co.
Fisher
Fluent Bioscienceshttps://www.fluentbio.com/scRNA-Seqdiscovery/developmentUSABob Wikle (sales@fluentbio.com; bwikle@fluentbio.com)
Forma Therapeutics
Fusion Genomicshttps://www.fusiongenomics.com/genetic testing, environmental DNA, infectious diseaseend-user, discovery/developmentCanadaShin Shing Hei Zhan (szhan@fusiongenomics.com)
Future Fieldshttps://futurefields.io/biomanifacturing, proteins, environment/sustainabilitymaterials distributorCanadaMatt Anderson-Baron (matt@futurefields.com)
Gairdnercelia@gairdner.org / janet.rossant@sickkids.ca2023
Galenvshttps://galenvs.com/nanoparticles and diagnosticsdiscovery/developmentCanadaJamal Daoud (jdaoud@galenvs.com)
Galenvs SciencesMontrealQuebecOligos, plasmid prep, nanomaterialswww.galenvs.com
GE Healtcareask Munndy Wellinger Raymund.Wellinger@USherbrooke.ca2015
Gene Toolsjmoulton@gene-tools.com
Gene Tools LLC
GeneTetherKelownaBritish Columbiawww.genetether.com
Genevanthttps://www.genevant.com/nucleic acid drugs and deliverydiscovery/development, end-userCanada/USAJames Heyes (LinkedIn: https://www.linkedin.com/in/james-heyes-67a98796/)https://www.genevant.com/contact-us/
Genome Canadahttps://genomecanada.ca/support and invest in biotech development in Canadadiscovery/development, consultingCanadaMr. Rob Annan (rannan@genomecanada.ca)From website: https://genomecanada.ca/contact-us/, info@genomecanada.ca , 613-751-4460
GenScript
Gentegrajamesn@gentegra.com
Ghost Tree Capital
Gilead CanadaMississaugaOntarioDelivery - LNPwww.gilead.ca
GLGhttps://glginsights.com/linking with RNA expertsconsultingUSAAlison Davis (adavis@glgroup.com)
Glysantis (Mirexus subsidiary)GuelphOntariowww.mirexusbiotech.com/glysantis
Gowlinghttps://gowlingwlg.com/en/various services (e.g. legal advice, marketing, finance) for companies including biotech and medicineconsultingCanada and globalGeorge Elvira (george.elvira@gowlingwlg.com)
Greenlight Bioscienceshttps://www.greenlightbiosciences.com/RNA for agricultural solutions (bees, fungal pathogens, insecticides, fungicides, herbicides)discovery/development, end-userUSAsponsors from European RNA meeting. contact@greenlightbiosciences.com +1(617)-616-8188
GSKhttps://www.gsk.com/en-gb/global pharmaceutical companymaterials distributorCanadaChris Cummins (linkedin)https://www.gsk.com/en-gb/contact-us/ , +44 20 8047 5000
Hermay Labshttps://hermaylabs.com/synthetic chemistry, pharmaceutical, medicinematerials distributorCanadaJohn Yao (jyao@hermay.ca)
IDTask Munndy Wellinger Raymund.Wellinger@USherbrooke.ca2016
IDT (Integrated DNA Technologies)https://www.idtdna.com/pagesDNA Technologiesdiscovery/developmentglobal
iganpartners
Illuminahttps://www.illumina.com/large pharmaceutical companydiscovery/developmentCanada and globalmbarnes1@illumina.com / eleblond@illumina.com
Immaginakirchrath@immaginabiotech.com
Immune Biosolutionhttps://immunebiosolutions.com/en/antibody immunotherapiesdiscovery/developmentCanada
Inceptivehttps://inceptive.life/RNA technologydiscovery/developmentUSAinfo@inceptive.life , +1 (650) 507-4490
Incisive GeneticsVancouverBritish Columbiawww.incisivegenetics.com
Incyte
Innovative Medicines Canadahttps://innovativemedicines.ca/support biotech development in Canadadiscovery/development, consultingCanadaMrs. Pamela Fralick, President (pfralick@imc-mnc.ca)
INSPQ (Institut National de la Santé Publique du Québec)https://www.inspq.qc.ca/enQuébec health agency (includes diagnostic labs and establishes standardized protocols/procedures/etc)CanadaHughes Charest (Hugues.charest@inspq.qc.ca); Donal Murphy (Donald.murphy@inspq.qc.ca)
Integrated NanotherapeuticsVancouverBritish ColumbiaDelivery - LNPwww.integratedntx.com
Ionis Pharmaceuticals
Jazz PharmaceuticalsMississaugaOntarioDelivery - LNPwww.jazzpharma.com
JenThera Therapeuticshttps://www.jenthera.com/CRISPR gene editingdiscovery/developmentCanadaFrom website: info@jenthera.com
KABShttps://kabs.com/biomanufacturing and various services (RNA?); https://kabs.com/ ; Québecdiscovery/development, consultingCanadaJean-Simon Blais, founder (450) 656-4404)https://kabs.com/contact/
KernalBiohttps://www.kernalbio.com/RNA therapeutics with selective targeting for cancerdiscovery/developmentUSAsponsors from European RNA meeting. bd@kernalbio.com
Keros Therapeutics
Korro Biohttps://www.korrobio.com/RNA editing for genetic diseasediscovery/developmentUSAsponsors from European RNA meeting. Media Contact: Glenn Silver (Glenn.silver@finnpartners.com) Partnering Inquiries: partnering@korrobio.com
Lab Chip Technologieshttps://labchiptechnologies.com/medical, environmentaldiscovery/developmentCanadaSeyed Azmayesh-Fard (seyeda@ulalberta.ca)
Ladder Therapeuticshttps://www.stevenagecatalyst.com/community/organisations/ladder-therapeutics/Therapies targeting RNA stuctures/foldingdiscovery/developmentCanada/USARabia Khan (rabia@laddertx.com)
Life Technologies2009
LifeSci Capital
MarkerHealth
MBLskitamur@mblintl.com Shinobu Kitamura, Ph.D., Vice President, Business Development)2013
MeiraGTx
Meros Polymershttps://www.merospolymers.com/drug delivery, genetic therapiesdiscovery/development, materials distributorCanadaAfsaneh Lavasanifar (afsaneh@ulberta.ca)
miRNA TherapeuticsNANAUSAhttps://www.linkedin.com/in/matt-winkler-8301567/sponsors from European RNA meeting. Unclear if stil operating.
Modelishttps://modelisdotca.wordpress.com/disease models in C.elegans and zebrafish (Montreal)discovery/developmentCanadaJames Doyle (CEO) (james.doyle@modelis.ca)
Modernahttps://www.modernatx.com/en-CAmRNA Vaccines, LNPs, mRNA delivery and therapeuticsdiscovery/development, end-userUSA/CanadaManuella.Bouttier@modernatx.com and Rahbar Rahimpour Have a partnership with McGill regarding mRNA delivery and LNP
Molecular Forecasterhttps://molecularforecaster.com/pharmaceuticals, modelling software, biomolecule designdiscovery/developmentCanadaJoshua Pottel (josh.pottel@molecularforecaster.com), Nicolas Moitessier (nicolas.moitessier@mcgill.ca)
Molecular Instrumentsjoyce@molecularinstruments.com
MycoDev GroupFrederictonNew BrunswickDelivery - Chitosanwww.mycodevgroup.com
NanoCorepieterc@mail.ubc.ca, dominik.witzigmann@unibas.ch
Nanora Pharmadrug delivery, genetic therapiesdiscovery/developmentCanadaunclear if still operating
NanoVation Therapeuticshttps://nanovationtx.com/lipid nanoparticle encapuslaiton of RNAdiscovery/developmentCanada/EuropeDominik Witzigmann (dominik.witzigmann@unibas.ch)
NCR Research Press2011
NeoaptamersLondonOntarioAptamerswww.neoaptamers.com
New England Biolab (NEB)https://www.neb.ca/materials for PCR, sequencing, etc.materials distributorUSA and globalrochette@neb.com (Ale Rochette)info.ca@neb.com
NMX solutionshttps://www.nmxresearch.com/drug screening, including for RNA targetsdiscovery/developmentCanadaSteven LaPlante (Steven.LaPlante@inrs.ca), Patricia.Bouchard@nmxresearch.com
Noble Insight
Norgen Biotek Corp
Northern RNACalgaryAlbertawww.northernrna.com
Northern RNA (Calgary)https://northernrna.com/supply nucleic acid productsmaterials distributorCanadainfo@northernrna.com 866 678 4762
Novogene
Nutcrackerhttps://www.nutcrackerx.com/RNA therapeutics for different cancersdiscovery/developmentUSAsponsors from European RNA meeting. https://www.nutcrackerx.com/contact/ (415) 906 0733
NuVesslCalgaryAlbertaDelivery - LNPwww.nuvessl.com
Oligo Medicwww.oligomedic.comdrug delivery, genetic therapiesdiscovery/developmentCanadaFrom website: info@oligomedic.com, +1 450 680 3371
Oncodesignhttps://www.oncodesign.com/treatment resistance and metastasisdiscovery/development, end-userFranceinfo@oncodesign.com +33 310 451 820
Open Healthrebeccaclarke@openhealthgroup.com
Orbital Therapeutics
ORNAhttps://www.ornatx.com/circular RNA therapeuticsdiscovery/developmentUSAsponsors from European RNA meeting. info@ornatx.com
Ovensahttps://ovensa.com/siRNA nanotherapeutic silencing the overexpression of galectin-1 https://ovensa.com/science/ ; cité de la Biotech (Laval)discovery/developmentCanadainfo@ovensa.com; narain@ualberta.ca
Oxford Nanoporehttps://nanoporetech.com/sequencing and molecular sensing devices, analysismaterials distributorUSA and globalnaoko.goto@nanoporetech.comhttps://nanoporetech.com/contact, +1 (212) 202 1712
Pacbiohkuftinec@pacificbiosciences.com
Pacific Biosciencehttps://www.pacb.com/sequencing technologymaterials distributorglobalGrace Murray (gmurray@pacificbiosciences.com)
Paraza PharmaMontrealQuebecmRNA translation, Polysome profiling
Parazapharmahttps://parazapharma.com/many RNA-unrelated activites, also mRNA translation assays: 35S-methionine (or puromycin) incorporation, Polysome profiling; https://parazapharma.com/; cité de la Biotech, Laval (+2 other Canadian site + Cambridge)discovery/developmentCanadaArshad Siddiqui (CEO, arshad.siddiqui@parazapharma.com)info@parazapharma.com
Pendant BiosciencesTorontoOntariowww.pendantbio.com
Perha Pharmaceuticalshttps://www.perha-pharma.com/kinase inhibitors in cognitive disorder and prevention of hearing lossdiscovery/development, end-userFrancehttps://www.perha-pharma.com/contact
Perkin elmerwenwen.tan@perkinelmer.com
Pfizerhttps://www.pfizer.ca/enpharmaceutical companymaterials distributorUSAJohn Androsavich (john.androsavich@pfizer.com)
Phoenix Molecular DesignVancouverBritish Columbiawww.phoenixmd.ca
PO-Laboratorieswww.po-labs.comnanotechnology, mass spectrometry, drug deliverydiscovery/developmentCanadainfo@po-labs.com , +1 514-212-2157
Polaris Oligohttps://www.polarisoligos.com/speciality/custom oligonucleotidesdiscovery/developmentCanadaJulien Poupart (j.poupart@polarisoligos.com) and ma.poupart@polarisoligos.com
Polaris OligonucleotidesLavalQuebecOligo synthesisOligonucleotide chemistry and synthesis
Polypus
Portage BiotechTorontoOntariowww.portagebiotech.com
Precision NanoSystemshttps://www.precisionnanosystems.com/mRNA LNP productiondiscovery/development, end-userCanadaSamuel Clarke (samuel_clarke@pall.com)
Prioris.aihttp://prioris.ai/predictive modelling, pharmaceutical, biotechnology, statistics and machine learningdiscovery/developmentCanadaStan Lazic
ProMabhttps://www.promab.com/nanoparticles, mRNA LNPsmaterials distributorUSA and globalhttps://www.promab.com/contact-us
Protagonist Therapeutics
Providence Therapeuticshttps://providencetherapeutics.com/mRNA Vaccinesdiscovery/developmentCanadaNatalia Martin Orozco CSO (linkedin.com/in/natalia-martin-orozco-a292b031), https://providencetherapeutics.com/contact.html
PTC Therapeuticshttps://www.ptcbio.com/Alternative splicingdiscovery/development, end-userUSAChuck Romfo (cromfo@ptcbio.com)
PTC Therapeutics CanadaBurlingtonOntariowww.ptcbio.com
Rallybio LLC
RBCXhttps://www.rbcx.com/supports tech companies, may have interest in biotech companies as wellconsultingCanadaPierre Bedikian (pierre.bedikian@rbc.com)Linked to RBC Bank
Regulushttps://www.regulusrx.com/RNA targeting miRNAs in genetic kidney diseasediscovery/developmentUSAsponsors from European RNA meeting. https://www.regulusrx.com/about/ 1-888-REGULUS (734-8587)
Remix Therapeuticshttps://www.remixtx.com/small molecules targeting RNA, drug discoverydiscovery/developmentUSAPete Smith (psmith@remixtx.com), fvaillancourt@remixtx.com
Rena biotechhttps://qcse.ca/en/success-story/mohammed/biosensors, aptazymesdiscovery/development, end-userCanadaReza Naghdi (mohammadreza.naghdi@inrs.ca)
Renabiotechmohammadreza.naghdi@inrs.ca
Resiliencehttps://resilience.com/explore/nucleic-acids/biomanufacturing, including optimized RNA and LNPs; https://resilience.com/; Ontariodiscovery/developmentCanada18887372460
Resilience BiotechnologiesMississaugaOntariowww.resilience.com
RevvityMadelein.Gregory@horizondiscovery.com2023
Rivella
RJH Bioscienceshttps://rjhbiosciences.com/delivery, nucleic acidsdiscovery/development, materials distributorCanadaHasan Uludag (uludag.rjh@gmail.com)
RNA Biology Journaljennifer.stokes@tandf.co.uk
RNA Diagnosticshttps://rnadiagnostics.com/chemotherapy guidancediscovery/developmentCanada
RNA Society (K. Baker)rna@rnasociety.orgnon-profit international scientific societyUSA#ERROR!
RNA technologies & therapeuticshttps://www.rnatechnologies.com/mRNA Design, Production and Screening for Your Therapeutics R&D Needs ; cité de la Biotech (Laval)discovery/developmentCanadaClaude Leduc (leduc@rnatechnologies.com)
Robic S.E.N.C.R.Lhttps://www.robic.ca/intellectual property and legal advice, including for biotech and medicineconsultingCanada and globalCharles Goyer (goyer@robic.com)Personnel: https://www.robic.ca/professionnels/
Roche Canadahttps://www.rochecanada.com/RNA-based diagnostics, more RNA-related activities?; https://www.rochecanada.com/; Cité de la Biotech, Laval (and more)discovery/developmentCanada
Samsung Biologicshttps://samsungbiologics.com/biopharmaceutical, productiondiscovery/developmentKoreaErin Keraghan
Sanofihttps://www.sanofi.com/enlarge pharmaceutical companydiscovery/development, end-userCanada and globalClaire Tardiveau (Claire.Tardiveau@sanofi.com)
Sanofi Aventis U.S.
Sartorius
Shape Therapeuticshttps://shapetx.com/AI & RNA, of repairing the genetic causes of disease (gene therapy?, RNA editing(ADAR), replacement and skipping (tRNA-for non sense stop); ;https://shapetx.com/;discovery/developmentUSAFrançois Vigneault (CEO)
Shine-Dalgorno Centre
Singleron Biotechnologies
siRNAomicshttps://sirnaomics.com/silencing RNAs for diseasediscovery/development, end-userChina / USAsponsors from European RNA meeting. Contact for American site: +1 301-740-1730 info-us@sirnaomics.com
Sixfold Biosciencehttps://www.sixfold.bio/RNA therapeuticsdiscovery/developmentUnited KingdomIoanna Mylonaki (https://uk.linkedin.com/in/ioanna-mylonaki-718b5441)
Skyhawk Therapeuticshttps://www.skyhawktx.com/Library testing on patient cells to identify potential drug candidatesdiscovery/developmentUSA/SwitzerlandFrom website: services@avantorsciences.com
Slingshot Insights
SmokePondbiomanufacturing, mRNA vaccinediscovery/development, end-userCanadaRasmus Rojkjaer (rasmus@smokepond.com)
Solstarhttps://solstarpharma.com/nucleic acid therapies (siRNA), cité de la Biotech (Laval)discovery/developmentCanadaDennis Baltzis (dennis.baltzis@solstarpharma.com), info@solstarpharma.com
Solstar Pharmahttps://www.solstarpharma.com/siRNA medicinediscovery/development, end-userCanadainfo@solstarpharma.com , ‪(514) 405-1180‬
Somalogic
Specific BiologicsTorontoOntariowww.specificbiologics.com
Spexis AG
Spindle BiotechTorontoOntariowww.spindle.bio
Squibb
Starpax BiopharmaMontrealQuebecMagnetoDroneswww.starpaxbiopharma.com
StemCellhttps://www.stemcell.com/Stem cells / Gene editing toolsmaterials distributorCanadaAnat Feldman (https://www.linkedin.com/in/anat-feldman-phd-mba-047a0217/)
StemRNANANANANANAsponsors from European RNA meeting. Unclear if an organization. StemRNA is a product of ReproCell.
Stoke Therapeuticshttps://www.stoketherapeutics.com/RNA therapeutics for disorders caused by protein difficienciesdiscovery/developmentUSAsponsors from European RNA meeting. Dawn Kalmar (Chief Communications Officer) 781-303-8302 dkalmar@stoketherapeutics.com
Strand Therapeuticshttps://www.strandtx.com/mRNA therapeutics and synthetic biologydiscovery/developmentUSAJake Becraft (https://www.linkedin.com/in/jacob-becraft-biotech)
Sunshine Biopharmawww.sunshinebiopharma.commRNA Therapiesdiscovery/developmentCanadanfo@sunshinebiopharma.com, 514-426-6161
Symvivohttps://www.symvivo.com/bacteria used for gene therapy (plasmid delivery); https://www.symvivo.com/; Burnabydiscovery/developmentCanada
Takeda
Takeda Pharmaceuticalshttps://www.takeda.com/Pharmaceutical company; RNA therapeutics and targeting via small RNAsdiscovery/developmentJapan / CanadaJerome Waldispuhl (jerome.waldispuhl@mcgill.ca)collaboration with Takeda Pharmaceuticals; https://genomequebec.com/en/funded-projects/assembly-of-a-massive-data-set-to-train-a-predictor-of-small-molecules-targeting-rnas/
Tatum Biosciencehttps://www.tatumbio.com/immunotherapy, bacteriophages, cancerdiscovery/developmentCanadaJean-Francois Millau (millau.jf@tatumbio.com)
Tecanask Munndy Wellinger Raymund.Wellinger@USherbrooke.ca2012
Techspert.io
TriLink Biotechnologieshttps://www.trilinkbiotech.com/mRNA synthesisdiscovery/developmentUSA(858) 617-8858 , https://www.trilinkbiotech.com/contact-us
TwentyEight Seven
TwentyEight Seven (currently Redona Therapeutics)https://www.twentyeight-seven.com/small molecule drugs against nucleic acid regulators for cancer and autoimmune diseasesdiscovery/developmentUSAsponsors from European RNA meeting. contact@redonatx.com. (617) 603 6060
UBC RNA Corehttps://csmb-scbm.ca/core-facility-director-rna-formulation-core-facility-ubc/RNA Core at universitydiscovery/developmentCanadaAndrew Varleyhttps://www.linkedin.com/in/andrewjvarley?originalSubdomain=ca
VBI vaccineshttps://www.vbivaccines.com/vaccines with virus-like particles, including for Zika and coronaviruses; https://www.vbivaccines.com/; Ontariodiscovery/developmentCanada and USACanada: (613) 749-4200, USA: info@vbivaccines.com, (617) 830-3031
venBio Select LLX
Vesigen Txhttps://www.vesigen.com/vesicle engineering to deliver RNA therapeuticsdiscovery/development, end-userUSAsponsors from European RNA meeting. info@vesigen.com
Virocarbhttps://virocarb.com/Antiviral drug developmentdiscovery/developmentCanadaAlan Cochrane (alan.cochrane@utoronto.ca)
Virogin BiotechVancouverBritish Columbiawww.virogin.com
Vizgen
VWRmark.gravelle@avantorsciences.com2017
Zymo ResearchSSanchez@zymoresearch.com (Sandy Sanchez)2019